Holen Sie sich die Stockscreener-App
9.47
3.37%
-0.33
Handel nachbörslich:
9.47
Schlusskurs vom Vortag:
$9.80
Offen:
$9.94
24-Stunden-Volumen:
168.36K
Relative Volume:
1.32
Marktkapitalisierung:
$308.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-7.07%
1M Leistung:
+6.88%
6M Leistung:
-24.12%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.26
$9.9708
1-Wochen-Bereich:
$9.26
$10.28
52-Wochen-Spanne:
$6.565
$13.47
Jade Biosciences Inc Stock (JBIO) Company Profile
Firmenname
Jade Biosciences Inc
Sektor
Branche
Telefon
617-443-2400
Adresse
930 WINTER STREET, WALTHAM
Vergleichen Sie JBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
9.47 | 450.75M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-09 | Eingeleitet | BTIG Research | Buy |
| 2025-07-14 | Eingeleitet | Jefferies | Buy |
| 2025-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-05-07 | Eingeleitet | Wedbush | Outperform |
| 2025-05-05 | Eingeleitet | Stifel | Buy |
| 2025-05-02 | Eingeleitet | TD Cowen | Buy |
| 2024-06-18 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-06-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-03-25 | Fortgesetzt | Jefferies | Buy |
| 2023-12-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-12-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-08-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-02-11 | Eingeleitet | BTIG Research | Buy |
| 2021-07-26 | Eingeleitet | Cowen | Outperform |
| 2021-07-26 | Eingeleitet | Evercore ISI | Outperform |
| 2021-07-26 | Eingeleitet | Jefferies | Buy |
| 2021-07-26 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten
How Jade Biosciences Inc. stock reacts to Fed rate cutsBull Run & Weekly High Potential Stock Alerts - newser.com
Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance
Will Jade Biosciences Inc. see short term momentumMarket Growth Review & Low Risk Entry Point Tips - newser.com
Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Jade Biosciences (NASDAQ:JBIO) Receives "Sell (E)" Rating from Weiss Ratings - MarketBeat
How Jade Biosciences Inc. stock reacts to inflationary pressures2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
How Jade Biosciences Inc. stock performs during Fed tightening cyclesWeekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com
Is Jade Biosciences Inc. stock positioned for long term growthQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Will Jade Biosciences Inc. stock see PE expansionWeekly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Is Jade Biosciences Inc. forming a reversal pattern2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Jade Biosciences Advances with Phase 1 Study of JADE101 - TipRanks
Jade Biosciences (JBIO) Price Target Increased by 13.43% to 19.38 - Nasdaq
Will Jade Biosciences Inc. stock keep outperforming rivals2025 Key Lessons & Real-Time Chart Pattern Alerts - fcp.pa.gov.br
Multi asset correlation models including Jade Biosciences Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - newser.com
What technical charts say about Jade Biosciences Inc. stockJuly 2025 Analyst Calls & Weekly High Conviction Ideas - fcp.pa.gov.br
Aug Summary: Will Jade Biosciences Inc. stock benefit from automationQuarterly Performance Summary & Community Driven Trade Alerts - fcp.pa.gov.br
Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)
Es liegen keine Finanzdaten für Jade Biosciences Inc (JBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):